Johnson Christine M, Pandey Rajesh, Sharma Sadhna, Khuller G K, Basaraba Randall J, Orme Ian M, Lenaerts Anne J
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, 80523-1682, USA.
Antimicrob Agents Chemother. 2005 Oct;49(10):4335-8. doi: 10.1128/AAC.49.10.4335-4338.2005.
We evaluated the efficacy of nanoparticle-encapsulated antituberculosis drugs administered every 10 days versus that of daily nonencapsulated drugs against Mycobacterium tuberculosis aerosol infection in guinea pigs. Both treatments significantly reduced the bacterial count and lung histopathology, suggesting that the nanoparticle drug delivery system has potential in intermitted treatment of tuberculosis.
我们评估了每10天给药一次的纳米颗粒包裹抗结核药物与每日给予的非包裹药物相比,对豚鼠结核分枝杆菌气溶胶感染的疗效。两种治疗方法均显著降低了细菌数量和肺部组织病理学变化,这表明纳米颗粒给药系统在结核病间歇治疗方面具有潜力。